noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

IHSA - Illinois High School[...]

Lincoln-Way East Quarterback Jonas Williams Rewrites State Passing Records
Oracle Corporation

Oracle Database@Google Cloud is Now Available in India
Ohio Auditor of State

Audit Advisory for Tuesday, December 16, 2025

Healthcare

Malin Corporation plc

01/23/2017 | Press release | Archived content

Kymab appoints Dr Arndt Schottelius as Executive Vice President Research & Development

Kymab Group Limited ("Kymab"), a leading human monoclonal antibody biopharmaceutical group, announced today the appointment of Dr Arndt Schottelius as its first Executive Vice President Research & Development. Dr Schottelius will lead the Research and Development activities, including pre-clinical and clinical developments of Kymab's expanding therapeutic antibody portfolio. The appointment will take effect in May 2017.

Read the full press release

Malin Corporation plc published this content on January 23, 2017, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 22, 2025 at 09:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]